Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borg, H.
Right arrow Articles by Sundkvist, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borg, H.
Right arrow Articles by Sundkvist, G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:1754-1762, 2002
© 2002 by the American Diabetes Association, Inc.

A 12-Year Prospective Study of the Relationship Between Islet Antibodies and ß-Cell Function At and After the Diagnosis in Patients With Adult-Onset Diabetes

Henrik Borg1, Anders Gottsäter2, Per Fernlund3, and Göran Sundkvist1

1 Department of Endocrinology, Lund University, Malmö University Hospital, Malmö, Sweden
2 Department of Vascular Diseases, Lund University, Malmö University Hospital, Malmö, Sweden
3 Department of Clinical Chemistry, Lund University, Malmö University Hospital, Malmö, Sweden

To clarify the relationships between islet antibodies (islet cell antibody [ICA], GAD antibody [GADA], and IA-2 antibody [IA-2A]) versus the progression of ß-cell dysfunction, we have followed a group of diabetic patients from their diagnosis at 21–73 years of age. Patients with ICA had high levels of GADA and/or IA-2A at diagnosis and a more severe ß-cell dysfunction 5 years after diagnosis than those with only GADA in low concentrations. The aim of the current 12-year follow-up study was to examine the further progression of ß-cell dysfunction in relation to islet antibodies at and after diagnosis. Among 107 patients, complete ß-cell failure 12 years after diagnosis was restricted to those with islet antibodies at diagnosis (16 of 21 [77%] with multiple antibodies and 4 of 5 [80%] with only GADA). In contrast, among antibody-negative patients, fasting P-C-peptide levels were unchanged. Most GADA-positive patients (22 of 27 [81%]) remained GADA positive after 12 years. Associated with decreasing fasting P-C-peptide levels (0.85 nmol/l [0.84] at diagnosis vs. 0.51 nmol/l [0.21] 12 years after diagnosis, P < 0.05), ICA developed after diagnosis in 6 of 105 originally antibody negative mostly overweight patients. In conclusion, multiple islet antibodies or GADA alone at diagnosis of diabetes predict future complete ß-cell failure. After diagnosis, GADA persisted in most patients, whereas ICA development in patients who were antibody negative at diagnosis indicated decreasing ß-cell function.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
A. K. Steck and G. S. Eisenbarth
Genetic Similarities Between Latent Autoimmune Diabetes and Type 1 and Type 2 Diabetes
Diabetes, May 1, 2008; 57(5): 1160 - 1162.
[Full Text] [PDF]


Home page
Diabetes CareHome page
G. E. Umpierrez
Ketosis-Prone Type 2 Diabetes: Time to revise the classification of diabetes
Diabetes Care, December 1, 2006; 29(12): 2755 - 2757.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Barinas-Mitchell, L. H. Kuller, S. Pietropaolo, Y.-J. Zhang, T. Henderson, and M. Pietropaolo
The Prevalence of the 65-Kilodalton Isoform of Glutamic Acid Decarboxylase Autoantibodies by Glucose Tolerance Status in Elderly Patients from the Cardiovascular Health Study
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2871 - 2877.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
G. E. Umpierrez, D. Smiley, and A. E. Kitabchi
Narrative review: ketosis-prone type 2 diabetes mellitus.
Ann Intern Med, March 7, 2006; 144(5): 350 - 357.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Pihoker, L. K. Gilliam, C. S. Hampe, and A. Lernmark
Autoantibodies in Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S52 - S61.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Stenstrom, A. Gottsater, E. Bakhtadze, B. Berger, and G. Sundkvist
Latent Autoimmune Diabetes in Adults: Definition, Prevalence, {beta}-Cell Function, and Treatment
Diabetes, December 1, 2005; 54(suppl_2): S68 - S72.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Biesenbach, M. Auinger, M. Clodi, F. Prischl, R. Kramar, and Diabetic Nephropathy Study Group of the Austrian S
Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria
Nephrol. Dial. Transplant., March 1, 2005; 20(3): 559 - 565.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. Bruno, F. Cerutti, F. Merletti, P. Cavallo-Perin, E. Gandolfo, M. Rivetti, C. Runzo, S. Pinach, G. Pagano, and The Piedmont Study Group for Diabetes Epidemiology
Residual {beta}-Cell Function and Male/Female Ratio Are Higher in Incident Young Adults Than in Children: The registry of type 1 diabetes of the province of Turin, Italy, 1984-2000
Diabetes Care, February 1, 2005; 28(2): 312 - 317.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
X LI, Z G ZHOU, G HUANG, X YAN, L YANG, X Y CHEN, and J P WANG
Optimal Cutoff Point of Glutamate Decarboxylase Antibody Titers in Differentiating Two Subtypes of Adult-Onset Latent Autoimmune Diabetes
Ann. N.Y. Acad. Sci., December 1, 2004; 1037(1): 122 - 126.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Maioli, E. Alejandro, G. Tonolo, L. K. Gilliam, L. Bekris, C. S. Hampe, D. A. Obinu, A. Manconi, L. Puddu, K. Lynch, et al.
Epitope-Restricted 65-Kilodalton Glutamic Acid Decarboxylase Autoantibodies among New-Onset Sardinian Type 2 Diabetes Patients Define Phenotypes of Autoimmune Diabetes
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5675 - 5682.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Tanaka, T. Endo, K. Aida, H. Shimura, N. Yokomori, M. Kaneshige, F. Furuya, S. Amemiya, M. Mochizuki, K. Nakanishi, et al.
Distinct Diagnostic Criteria of Fulminant Type 1 Diabetes Based on Serum C-Peptide Response and HbA1c Levels at Onset
Diabetes Care, August 1, 2004; 27(8): 1936 - 1941.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. Barinas-Mitchell, S. Pietropaolo, Y.-J. Zhang, T. Henderson, M. Trucco, L. H. Kuller, and M. Pietropaolo
Islet Cell Autoimmunity in a Triethnic Adult Population of the Third National Health and Nutrition Examination Survey
Diabetes, May 1, 2004; 53(5): 1293 - 1302.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. E. Kitabchi
Ketosis-Prone Diabetes--A New Subgroup of Patients with Atypical Type 1 and Type 2 Diabetes?
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5087 - 5089.
[Full Text] [PDF]


Home page
Diabetes CareHome page
K. R. Owen, A. Stride, S. Ellard, and A. T. Hattersley
Etiological Investigation of Diabetes in Young Adults Presenting With Apparent Type 2 Diabetes
Diabetes Care, July 1, 2003; 26(7): 2088 - 2093.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
G. Stenstrom, B. Berger, H. Borg, P. Fernlund, J. S. Dorman, and G. Sundkvist
HLA-DQ Genotypes in Classic Type 1 Diabetes and in Latent Autoimmune Diabetes of the Adult
Am. J. Epidemiol., November 1, 2002; 156(9): 787 - 796.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.